NCT03837730View on ClinicalTrials.gov

Citrulline and Arginase Activity in Severe Sepsis and Septic Shock

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

September 30, 2022

Study Completion Date

October 30, 2022

Conditions
Intensive Care UnitsInfectionBiomarkersSepsisSeptic Shock
Trial Locations (1)

25030

CHU de BESANCON, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT03837730 - Citrulline and Arginase Activity in Severe Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter